Literature DB >> 14874500

Treatment of lupus erythematosus with mepacrine.

F PAGE.   

Abstract

Entities:  

Keywords:  LUPUS ERYTHEMATOSUS/therapy; QUINACRINE/therapeutic use

Mesh:

Substances:

Year:  1951        PMID: 14874500     DOI: 10.1016/s0140-6736(51)91643-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  43 in total

1.  THE VALUE AND DANGERS OF ANTIMALARIAL THERAPY IN ARTHRITIS WITH SPECIAL RELATION TO OPHTHALMIC COMPLICATIONS.

Authors:  G D KERSLEY
Journal:  Proc R Soc Med       Date:  1964-08

2.  [Changes in the human electro-retinogram during long-term resochin therapy].

Authors:  B SCHMIDT; W MUELLER-LIMMROTH; G HEINMUELLER; W BOEKE; A BAEUMER
Journal:  Klin Wochenschr       Date:  1961-02-01

3.  Chloroquine diphosphate in rheumatoid arthritis. A controlled trial.

Authors:  A J POPERT; K A MEIJERS; J SHARP; F BIER
Journal:  Ann Rheum Dis       Date:  1961-03       Impact factor: 19.103

4.  Antimalarials in treatment of Sjogren's syndrome.

Authors:  J M HEATON
Journal:  Br Med J       Date:  1959-06-13

5.  Disturbances of pigmentation with chloroquine.

Authors:  J L DALL; J A KEANE
Journal:  Br Med J       Date:  1959-05-30

6.  [On the neurological syndrome in the framework of lupus erythematosus].

Authors:  W FUHRMANN; J NAWROTZKI
Journal:  Dtsch Z Nervenheilkd       Date:  1959

7.  Synthetic antimalarial drug therapy in lupus erythematosus and polymorphous light eruptions.

Authors:  J H EPSTEIN
Journal:  Calif Med       Date:  1960-02

8.  Treatment of rheumatoid arthritis with chloroquine.

Authors:  H FULD; L HORWICH
Journal:  Br Med J       Date:  1958-11-15

9.  [On visual disturbances and eye changes in quinoline therapy of primary chronic articular rheumatism].

Authors:  R MARX; P BRECH; T MEISNER
Journal:  Klin Wochenschr       Date:  1960-05-01

10.  The value of chloroquine in rheumatoid disease: a four-year study of continuous therapy.

Authors:  A W BAGNALL
Journal:  Can Med Assoc J       Date:  1957-08-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.